Boniva is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Ibandronate Sodium.
| Product ID | 0004-0186_4995d52a-c085-4716-abfd-12714c5c2cec |
| NDC | 0004-0186 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Boniva |
| Generic Name | Ibandronate Sodium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2005-03-24 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021455 |
| Labeler Name | Genentech, Inc. |
| Substance Name | IBANDRONATE SODIUM |
| Active Ingredient Strength | 150 mg/1 |
| Pharm Classes | Bisphosphonate [EPC],Diphosphonates [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2014-12-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021455 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-03-24 |
| Marketing End Date | 2019-01-31 |
| Marketing Category | NDA |
| Application Number | NDA021455 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-02-03 |
| Marketing End Date | 2015-01-13 |
| Marketing Category | NDA |
| Application Number | NDA021455 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-12-17 |
| Ingredient | Strength |
|---|---|
| IBANDRONATE SODIUM | 150 mg/1 |
| SPL SET ID: | 841bf769-0148-42a8-a4d0-ff062b4734e8 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0004-0186 | Boniva | ibandronate sodium |
| 0004-0191 | Boniva | ibandronate sodium |
| 23155-162 | Ibandronate sodium | Ibandronate sodium |
| 25021-827 | ibandronate sodium | ibandronate sodium |
| 33342-150 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 47781-103 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 51224-008 | IBANDRONATE SODIUM | Ibandronate Sodium |
| 55111-575 | Ibandronate sodium | Ibandronate sodium |
| 55150-191 | Ibandronate Sodium | Ibandronate Sodium |
| 60429-643 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 60505-2795 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 60505-6097 | Ibandronate Sodium | ibandronate sodium |
| 62756-218 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
| 65862-237 | Ibandronate Sodium | Ibandronate Sodium |
| 67457-524 | ibandronate sodium | ibandronate sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BONIVA 78404853 not registered Dead/Abandoned |
Roche Therapeutics Inc. 2004-04-20 |
![]() BONIVA 78392767 not registered Dead/Abandoned |
Boniva Software, Inc. 2004-03-29 |
![]() BONIVA 78209524 2931724 Live/Registered |
Roche Therapeutics Inc. 2003-01-31 |